Engineering interchain disulfide bonds into conserved framework regions of Fv fragments: improved biochemical characteristics of recombinant immunotoxins containing disulfide-stabilized Fv

Using molecular modeling technology, we have recently identifiedtwo positions in conserved framework regions of antibody Fvfragments (Fvs) that are distant from CDRs, and potentiallycan be used to make recombinant Fv fragments in which the unstableV_H and V_L heterodimer is stabilized by an interchain disulfidebond inserted between structurally conserved framework positions.A disulfide bond has been introduced at one of these positions,V_H44-V_L105, and shown to stabilize various Fvs that retain fullbinding and specificity. Recombinant immunotoxias, e.g. B3(dsFv)-PE38KDELin which this disulfide-stabilized Fv moiety is connected toa truncated form of Pseudomonas exotoxin (PE; PE38KDEL) whichcontains the translocation and ADP ribosylation domains, areindistinguishable in binding and specificity from its single-chainimmunotoxin counterparts. We have now analyzed the alternativeposition, (V_H111-V_L48), predicted by the modeling methodology,for disulfide stabilization of mAb B3(Fv) by producing a recombinantimmunotoxin with such disulfide-stabilized (ds) Fv. This immunotoxinwas also very active and retained full specificity to B3 antigen-positivecells. However, it was 2- to 3-fold less active than the V_H44-V_L105dsFv-molecule. We also tested various biochemical features ofV_H44-V_L105 and V_H111-V_L48 dsFv immunotoxins and compared themwith the corresponding single-chain immunotoxin. We found thedsFv immunotoxins were more stable in human serum and more resistantto thermal and chemical denaturation than the single chain (sc)Fv immunotoxin. Because dsFv immunotoxins and dsFvs have fullactivity and specificity and improved stability, they may bemore useful than scFv immunotoxins as therapeutic and diagnosticagents.     

A Single-Domain Antibody-Based Anti-PSMA Recombinant Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Therapy

Prostate cancer (PCa) is the second most common cancer in men, causing more than 300,000 deaths every year worldwide. Due to their superior cell-killing ability and the relative simplicity of their preparation, immunotoxin molecules have great potential in the clinical treatment of cancer, and several such molecules have been approved for clinical application. In this study, we adopted a relatively simple strategy based on a single-domain antibody (sdAb) and an improved Pseudomonas exotoxin A (PE) toxin (PE24X7) to prepare a safer immunotoxin against prostate-specific membrane antigen (PSMA) for PCa treatment. The designed anti-PSMA immunotoxin, JVM-PE24X7, was conveniently prepared in its soluble form in an Escherichia coli (E. coli) system, avoiding the complex renaturation process needed for immunotoxin preparation by the conventional strategy. The product was very stable and showed a very strong ability to bind the PSMA receptor. Cytotoxicity assays showed that this molecule at a very low concentration could kill PSMA-positive PCa cells, with an EC₅₀ value (concentration at which the cell viability decreased by 50%) of 15.3 pM against PSMA-positive LNCaP cells. Moreover, this molecule showed very good killing selectivity between PSMA-positive and PSMA-negative cells, with a selection ratio of more than 300-fold. Animal studies showed that this molecule at a very low dosage (5 × 0.5 mg/kg once every three days) completely inhibited the growth of PCa tumors, and the maximum tolerable dose (MTD) was more than 15 mg/kg, indicating its very potent tumor-treatment ability and a wide therapeutic window. Use of the new PE toxin, PE24X7, as the effector moiety significantly reduced off-target toxicity and improved the therapeutic window of the immunotoxin. The above results demonstrate that the designed anti-PSMA immunotoxin, JVM-PE24X7, has good application value for the treatment of PCa.     

免疫毒素ScFv(anti HER2)-PE38的复性与纯化

目的建立免疫毒素ScFv(anti HER2)-PE38的分离纯化工艺。方法免疫毒素ScFv(anti HER2)-PE38变性后,进行金属螯合柱层析复性和纯化,再用分子筛层析进行精纯,SDS-PAGE分析纯化产物。结果包涵体形式存在的免疫毒素ScFv(anti HER2)-PE38以8 mol/L尿素溶解效果较好;当复性梯度为稀释液从0到100%,共用时150 min,流速为2 ml/min时,复性效果较好,复性后的目的蛋白纯度可达95%以上;以凝胶柱Superdex 200进行分子筛层析效果较好,纯化产物的纯度可达98%以上。结论已建立了免疫毒素ScFv(anti HER2)-PE38的分离纯化工艺,为进一步的研究奠定了基础。     

YES1 as a Therapeutic Target for HER2-Positive Breast Cancer after Trastuzumab and Trastuzumab-Emtansine (T-DM1) Resistance Development

Trastuzumab-emtansine (T-DM1) is a therapeutic agent molecularly targeting human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer (MBC), and it is especially effective for MBC with resistance to trastuzumab. Although several reports have described T-DM1 resistance, few have examined the mechanism underlying T-DM1 resistance after the development of acquired resistance to trastuzumab. We previously reported that YES1, a member of the Src family, plays an important role in acquired resistance to trastuzumab in HER2-amplified breast cancer cells. We newly established a trastuzumab/T-DM1-dual-resistant cell line and analyzed the resistance mechanisms in this cell line. At first, the T-DM1 effectively inhibited the YES1-amplified trastuzumab-resistant cell line, but resistance to T-DM1 gradually developed. YES1 amplification was further enhanced after acquired resistance to T-DM1 became apparent, and the knockdown of the YES1 or the administration of the Src inhibitor dasatinib restored sensitivity to T-DM1. Our results indicate that YES1 is also strongly associated with T-DM1 resistance after the development of acquired resistance to trastuzumab, and the continuous inhibition of YES1 is important for overcoming resistance to T-DM1.     

A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions

Synthetic antibody libraries have been used to generate antibodies with favorable biophysical and pharmacological properties. Here, we describe the design, construction, and validation of a phage-displayed antigen-binding fragment (Fab) library built on a modified trastuzumab framework with four fixed and two diversified complementarity-determining regions (CDRs). CDRs L1, L2, H1, and H2 were fixed to preserve the most commonly observed “canonical” CDR conformation preferred by the modified trastuzumab Fab framework. The library diversity was engineered within CDRs L3 and H3 by use of custom-designed trinucleotide phosphoramidite mixes and biased towards human antibody CDR sequences. The library contained ≈7.6 billion unique Fabs, and >95 % of the library correctly encoded both diversified CDR sequences. We used this library to conduct selections against the human epidermal growth factor receptor-3 extracellular domain (HER3-ECD) and compared the CDR diversity of the naïve library and the anti-HER3 selection pool by use of next-generation sequencing. The most commonly observed CDR combination isolated, named Her3-3, was overexpressed and purified in Fab and immunoglobulin G (IgG) formats. Fab HER3-3 bound to HER3-ECD with a K_D value of 2.14 nm and recognized cell-surface HER3. Although HER3-3 IgG bound to cell-surface HER3, it did not inhibit the proliferation of HER3-positive cells. Near-infrared imaging showed that Fab HER3-3 selectively accumulated in a murine HER3-postive xenograft, thus providing a lead for the development of HER3 imaging probes.     

Effect of TiO2 nanoparticles on the antibacterial and physical properties of polyethylene-based film

TiO₂ nanoparticles and their application in packaging systems have attracted a lot of attention because of its antimicrobial activity. In this work, effect of TiO₂ nanoparticles on the antibacterial and physical properties of polyethylene (PE)-based film was investigated. Results indicated that the antibacterial activity of TiO₂-incorporated PE films should be due to the killing effect property of TiO₂ nanoparticles against microorganisms. The TiO₂-incorporated PE film exhibited more effective antibacterial activity for Staphylococcus aureus. The antibacterial activity to inactivate Escherichia coli or S. aureus was improved by UV irradiation. The inhibition ratio of TiO₂-incorporated PE films sample irradiated for 60 min by UV light was improved significantly, which were 89.3% for E. coli and 95.2% for S. aureus, respectively, compared to that of TiO₂-PE film without UV irradiation. The analysis of physical properties revealed that TiO₂ nanoparticles increased the tensile strength and elongation at break of PE-based film. The climate resistance of nano-TiO₂ films is greatly enhanced, compared to that of the blank PE film. Water vapor transmission increased from 18.1 to 24.6 g/m²·24 h with the incorporation of TiO₂ nanoparticles. Results revealed that PE based film incorporating with TiO₂ nanoparticles have a good potential to be used as active food packaging system.     

Combination of Near-Infrared Photoimmunotherapy Using Trastuzumab and Small Protein Mimetic for HER2-Positive Breast Cancer

Near-infrared photoimmunotherapy (NIR-PIT) is a promising cancer therapy based on a monoclonal antibody conjugated to a photosensitizer (IR700Dye) that is activated by near-infrared light irradiation. We previously reported on the use of NIR-PIT with a small protein mimetic, the Affibody molecule (6–7 kDa), instead of a monoclonal antibody. In this study, we investigated a combination of NIR-PIT for HER2-positive breast cancer cells (SK-BR3, MDA-MB361, and JIMT1) with HER2 Affibody-IR700Dye conjugate and trastuzumab-IR700Dye conjugate. HER2 Affibody and trastuzumab target different epitopes of the HER2 protein and do not compete. In vitro, the combination of NIR-PIT using both HER2 Affibody-IR700Dye conjugate and trastuzumab-IR700Dye conjugate induced necrotic cell death of HER2-positive breast cancer cells without damage to HER2-negative breast cancer cells (MCF7). It was more efficient than NIR-PIT using either the HER2 Affibody-IR700Dye conjugate alone or the trastuzumab-IR700Dye conjugate alone. Additionally, this combination of NIR-PIT was significantly effective against HER2 low-expressing cancer cells, trastuzumab-resistant cells (JIMT1), and brain metastatic cells of breast cancer (MDA-MB361). Furthermore, in vivo imaging exhibited the strong fluorescence intensity of both HER2 Affibody-IR700Dye conjugates and trastuzumab-Alexa488 conjugates in HER2-positive tumor, indicating that both HER2 Affibody and trastuzumab specifically bind to HER2-positive tumors without competing with each other. In conclusion, the combination of NIR-PIT using both HER2 Affibody and trastuzumab expands the targeting scope of NIR-PIT for HER2-positive breast cancer.     

Novel Bacterial Production of Two Different Bioactive Forms of Human Stem-Cell Factor

Human stem-cell factor (hSCF) stimulates the survival, proliferation, and differentiation of hematopoietic cells by binding to the c-Kit receptor. Various applications of hSCF require the efficient and reliable production of hSCF. hSCF exists in three forms: as two membrane-spanning proteins hSCF248 and hSCF229 and truncated soluble N-terminal protein hSCF164. hSCF164 is known to be insoluble when expressed in Escherichia coli cytoplasm, requiring a complex refolding procedure. The activity of hSCF248 has never been studied. Here, we investigated novel production methods for recombinant hSCF164 and hSCF248 without the refolding process. To increase the solubility of hSCF164, maltose-binding protein (MBP) and protein disulfide isomerase b’a’ domain (PDIb’a’) tags were attached to the N-terminus of hSCF164. These fusion proteins were overexpressed in soluble form in the Origami 2(DE3) E. coli strain. These solubilization effects were enhanced at a low temperature. His-hSCF248, the poly-His tagged form of hSCF248, was expressed in a highly soluble form without a solubilization tag protein, which was unexpected because His-hSCF248 contains a transmembrane domain. hSCF164 was purified using affinity and ion-exchange chromatography, and His-hSCF248 was purified by ion-exchange and gel filtration chromatography. The purified proteins stimulated the proliferation of TF-1 cells. Interestingly, the EC₅₀ value of His-hSCF248 was 1 pg/mL, 100-fold lower than 9 ng/mL hSCF164. Additionally, His-hSCF248 decreased the doubling time, increased the proportion of S and G2/M stages in the cell cycle, and increased the c-Myc expression at a 1000-fold lower concentration than hSCF164. In conclusion, His-hSCF248 was expressed in a soluble form in E. coli and had stronger activity than hSCF164. The molecular chaperone, MBP, enabled the soluble overexpression of hSCF164.     

Soluble Prokaryotic Overexpression and Purification of Human GM-CSF Using the Protein Disulfide Isomerase b′a′ Domain

Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a member of the colony-stimulating factor (CSF) family, which functions to enhance the proliferation and differentiation of hematopoietic stem cells and other hematopoietic lineages such as neutrophils, dendritic cells, or macrophages. These proteins have thus generated considerable interest in clinical therapy research. A current obstacle to the prokaryotic production of human GM-CSF (hGM-CSF) is its low solubility when overexpressed and subsequent complex refolding processes. In our present study, the solubility of hGM-CSF was examined when combined with three N-terminal fusion tags in five E. coli strains at three different expression temperatures. In the five E. coli strains BL21 (DE3), ClearColi BL21 (DE3), LOBSTR, SHuffle T7 and Origami2 (DE3), the hexahistidine-tagged hGM-CSF showed the best expression but was insoluble in all cases at each examined temperature. Tagging with the maltose-binding protein (MBP) and the b′a′ domain of protein disulfide isomerase (PDIb′a′) greatly improved the soluble overexpression of hGM-CSF at 30 °C and 18 °C. The solubility was not improved using the Origami2 (DE3) and SHuffle T7 strains that have been engineered for disulfide bond formation. Two conventional chromatographic steps were used to purify hGM-CSF from the overexpressed PDIb′a′-hGM-CSF produced in ClearColi BL21 (DE3). In the experiment, 0.65 mg of hGM-CSF was isolated from a 0.5 L flask culture of these E. coli and showed a 98% purity by SDS-PAGE analysis and silver staining. The bioactivity of this purified hGM-CSF was measured at an EC₅₀ of 16.4 ± 2 pM by a CCK8 assay in TF-1 human erythroleukemia cells.     

Morphology and thermal properties in the binary blends of poly(propylene-co-ethylene) copolymer and isotactic polypropylene with polyethylene

The morphology and thermal properties of isothermal crystallized binary blends of poly(propylene-co-ethylene) copolymer (PP-co-PE) and isotactic polypropylene (iPP) with low molecular weight polyethylene (PE) were studied with differential scanning calorimeter (DSC), dynamic mechanical analysis (DMA), polarized optical microscopy (POM) and wide-angle X-ray diffraction (WAXD). In PP-co-PE/PE binary blends, however, the connected PE acted as a phase separating agent to promote phase separation for PP-co-PE/PE binary blends during crystallization. Therefore, the thermal properties of PP-co-PE/PE presented double melting peaks of PE and a single melting temperature of PP during melting trace; on the other hand, at cooling trace, the connected PE promoted crystallization rate because of enhanced segmental mobility of PP-co-PE during crystallization. At isothermal crystallization temperature between the melting points of iPP and PE, the binary blend was a crystalline/amorphous system resulting in persistent remarkable molten PE separated domains in the broken iPP spherulite. And then, when temperature was quenched to room temperature, the melted PE separated domains were crystallized that presented a crystalline/crystalline system and formed the intra-spherulite segregation morphology: these PE separated domains/droplet crystals contained mixed diluent PE with connected PE components. On the other hand, in the iPP/PE binary blends, the thermal properties showed only single melting peaks for both PE and iPP. Moreover, the glass transition temperature of iPP shifted to lower temperature with increasing PE content, implying that the diluent PE molecules were miscible with iPP to form two interfibrillar segregation morphologies: iPP-rich and PE-rich spherulites. In this work, therefore, we considered that the connected PE in PP-co-PE functioned as an effective phase separating agent for PP and diluent PE may be due to the miscibility between connected PE and diluent PE larger than that between PP and dispersed PE.     

Crystallization behavior of poly(β-propiolactone)-block-polyethylene copolymers with varying polyethylene crystallinities

The crystallization behavior of poly(β-propiolactone)-block-polyethylene (PPL-b-PE) copolymers with high PE crystallinities χ_PE (>0.30) has been examined using time-resolved synchrotron small-angle X-ray scattering and Fourier transform infrared spectroscopy, where the PE block crystallized first and subsequently the PPL block crystallized on quenching from a strongly segregated melt. The crystallization of PE blocks destroyed the lamellar microdomain structure (LMS) existing in the melt to form the crystalline lamellar morphology (CLM), and then PPL blocks crystallized within CLM. This morphology formation was compared to our previous results for the crystallization of PPL-b-PE copolymers with low χ_PE (0.12 < χ_PE < 0.26), where the crystallizability of PE blocks was not sufficiently large to destroy LMS. As a result, PE blocks crystallized promptly within LMS to reinforce and stabilize it against the subsequent crystallization of PPL blocks, yielding the confined crystallization of both blocks within LMS. We summarize these results including the case of χ_PE = 0, and propose three mechanisms of morphology formation occurring in PPL-b-PE copolymers according to χ_PE (i.e., high, low, or zero).     

A fold-back single-chain diabody format enhances the bioactivity of an anti-monkey CD3 recombinant diphtheria toxin-based immunotoxin

T-cell depleting anti-CD3 immunotoxins have utility in non-human primate models of transplantation tolerance and autoimmune disease therapy. We recently reported that an affinity matured single-chain (scFv) anti-monkey CD3 antibody, C207, had increased binding to T-cells and increased bioactivity in a diphtheria toxin (DT)-based biscFv immunotoxin compared with the parental antibody, FN18. However, FN18 scFvs and their mutant derivatives such as C207 did not exhibit robust bivalent character in the biscFv format. We now report that C207 in a diabody format exhibits a 7-fold increase in binding to T-cells over scFv (C207) indicating considerable divalent character for the diabody. This construct was formed by reducing the V(L)/V(H) linker to five residues and was secreted from Pichia pastoris as the non-covalent dimer. An immunotoxin based on this diabody format was secreted as a non-covalent dimer but was devoid of bioactivity and failed to bind T-cells, suggesting steric hindrance from the two large closely positioned truncated DT moieties. We constructed a single-chain diabody immunotoxin by fusing to the truncated DT C-terminus L1-VL-L1-VH-L2-VL-L1-VH where L1 is a five-residue linker and L2 is the longer (G4S)3 linker permitting interactions between the distal and proximal VL/VH domains. This 'fold-back' immunotoxin was secreted predominantly as the monomer and exhibited a 5- to 7-fold increase in bioactivity over DT390biscFv(C207) and depleted monkey T-cells in vivo.     

Distinct Mechanisms for Processing Autophagy Protein LC3-PE by RavZ and ATG4B

Autophagy is a conserved catabolic process involved in the elimination of proteins, organelles and pathogens in eukaryotic cells. Lipidated LC3 proteins that are conjugated to phosphatidylethanolamine (PE) play a key role in autophagosome biogenesis. Endogenous ATG4-mediated deconjugation of LC3-PE is required for LC3 recycling. However, the Legionella effector RavZ irreversibly deconjugates LC3-PE to inhibit autophagy. It is not clear how ATG4 and RavZ process LC3-PE with distinct modes. Herein, a series of semisynthetic LC3-PE proteins containing C-terminal mutations or insertions were used to investigate the relationship of the C-terminal structure of LC3-PE with ATG4/RavZ-mediated deconjugation. Using a combination of molecular docking and biochemical assays, we found that Gln116, Phe119 and Gly120 of LC3-PE are required for cleavage by both RavZ and ATG4B, whereas Glu117(LC3) is specific to cleavage by RavZ. The molecular ruler mechanism exists in the active site of ATG4B, but not in RavZ. Met63 and Gln64 at the active site of RavZ are involved in accommodating LC3 C-terminal motif. Our findings show that the distinct binding modes of the LC3 C-terminal motif (116–120) with ATG4 and RavZ might determine the specificity of cleavage site.     

Composition dependence of crystallized lamellar morphology formed in crystalline-crystalline diblock copolymers

We have investigated the crystallized morphology formed at each temperature T_c (20 °C ≤ T_c ≤ 45 °C) in double crystalline poly(?-caprolactone)-block-polyethylene (PCL-b-PE) copolymers as a function of composition (or volume fraction of PE blocks ?_PE) by employing small-angle X-ray scattering (SAXS) and differential scanning calorimetry (DSC) techniques. When PCL-b-PE with ?_PE ≤ 0.58 was quenched from a microphase-separated melt into T_c, the crystallization of PE blocks occurred first to yield an alternating structure consisting of thin PE crystals and amorphous PE + PCL layers (PE lamellar morphology) followed by the crystallization of PCL blocks, where we can expect a competition between the stability of the PE lamellar morphology (depending on ?_PE) and PCL crystallization (on T_c). Two different morphologies were formed in the system judging from a long period. That is, the PCL block crystallized within the existing PE lamellar morphology at lower T_c (<30 °C) to yield a double crystallized alternating structure while it crystallized by deforming or partially destroying the PE lamellar morphology at higher T_c (>35 °C) to result in a significant increase of the long period. However, the temperature at which the morphology changed was almost independent of ?_PE. For PCL-b-PE with ?_PE ≥ 0.73, on the other hand, the morphology after the crystallization of PE blocks was preserved at every T_c investigated.     

Crystallization behavior of poly(ε-caprolactone) blocks starting from polyethylene lamellar morphology in poly(ε-caprolactone)-block-polyethylene copolymers

The crystallization behavior of poly(ε-caprolactone) (PCL) blocks starting from a solid lamellar morphology formed in advance by the crystallization of polyethylene (PE) blocks (PE lamellar morphology) in a PCL-b-PE diblock copolymer was investigated by differential scanning calorimetry (DSC), small-angle X-ray scattering with synchrotron radiation (SR-SAXS), and polarized optical microscope (POM). The crystallization behavior was quantitatively compared with that of a PCL-block-polybutadiene copolymer, where the crystallization of PCL blocks started from a rubbery lamellar microdomain. DSC and SR-SAXS results revealed that the crystallization rate of PCL blocks in PCL-b-PE increased drastically with decreasing crystallization temperature T_c and the Avrami exponent depended significantly on T_c. SR-SAXS curves during the crystallization of PCL blocks at high T_c showed a bimodal scattering character, that is, the peak position moved discontinuously with crystallization time. At low T_c, on the other hand, no shift of the SAXS peak position was observed. The macroscopic change in morphology was detected only at high T_c by POM observations. These experimental results for the crystallization behavior of PCL blocks in PCL-b-PE all support our previous conclusions obtained by static measurements; the crystallization mechanism at low T_c is completely different from that at high T_c, that is, the PCL blocks crystallize within the PE lamellar morphology at low T_c while the crystallization of PCL blocks at high T_c yields a morphological transition from the PE lamellar morphology into a new solid morphology.     

Morphology of melt-quenched poly(ε-caprolactone)-block-polyethylene copolymers

The morphology of a melt-quenched crystalline-crystalline diblock copolymer, poly(ε-caprolactone)-block-polyethylene (PCL-b-PE), was studied by small-angle X-ray scattering and transmission electron microscopy. The melting behavior of PCL-b-PE was also investigated by differential scanning calorimetry. The melting temperature of PCL blocks, T_m,PCL, was ca. 55 °C and that of PE blocks was ca. 96 °C. Therefore, the PE block always crystallized first during quenching from the microphase-separated melt into various temperatures T_c below T_m,PCL to yield an alternating structure composed of PE lamellae and amorphous layers (PE lamellar morphology), and subsequently the crystallization of PCL blocks started at T_c after some induction period. The PE lamellar morphology was preserved after the crystallization of PCL blocks at low crystallization temperatures (T_c<30 °C), that is, the PCL block crystallized within the PE lamellar morphology. At high crystallization temperatures (45 °C>T_c>30 °C), on the other hand, the crystallization of PCL blocks destroyed the PE lamellar morphology to result in a new lamellar morphology mainly consisting of PCL lamellae and amorphous layers (PCL lamellar morphology). The PE crystals were fragmentarily dispersed in the PCL lamellar morphology.     

Extracellular Production of a Novel Endo-β-Agarase AgaA from Pseudomonas vesicularis MA103 that Cleaves Agarose into Neoagarotetraose and Neoagarohexaose

The gene agaA, of the isolated marine bacterium Pseudomonas vesicularis MA103, comprised 2958-bp nucleotides encoding a putative agarase AgaA of 985 amino acids, which was predicted to contain a signal peptide of 29 amino acids in the N-terminus, a catalytic domain of glycoside hydrolase 16 (GH16) family, a bacterial immunoglobulin group 2 (Big 2), and three carbohydrate binding modules 6 (CBM 6). The gene agaA was cloned and overexpressed in Escherichia coli, and the optimum temperatures for AgaA overexpression were 16, 20 and 24 °C. The agaA was cloned without its signal peptide for cytosolic production overexpression, whereas it was cloned with the heterologous signal peptide PelB and its endogenous signal peptide for periplasmic and extracellular productions, respectively. Extracellular and periplasmic rAgaA showed greater activity than that of cytosolic rAgaA, indicating that membrane translocation of AgaA may encourage proper protein folding. Time-course hydrolysis of agarose by rAgaA was accomplished and the products were analyzed using thin layer chromatography and matrix-assisted laser desorption inoization-time of flight mass spectrometry, indicating that AgaA from P. vesicularis was an endo-type β-1,4 agarase that cleaved agarose into neoagarotetraose and neoagarohexaose as the final products.     

Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation

Using molecular modeling technology we have recently identifiedpositions in conserved framework regions of Fvs which can beused to stabilize antibody Fvs by an interchain disulfide bondengineered in between the structurally conserved framework positionsof the variable domains of heavy (V_H) and light (V_L) immunoglobulinchains (disulfide-stabilized Fv; dsFv). The computer model indicatedthe existence of other potential sites in the framework regionsthat might be suitable for disulfide bond formation betweenV_H and V_L. The possibility of obtaining dsFvs using these positionsis evaluated here experimentally by constructing dsFv immunotoxinsin which the Fv moiety is fused to a truncated form of Pseudomonasexotoxin. We analyzed the extent of dsFv formation and the activityof the resulting dsFv immunotoxins, and compared various dsFvmolecules with the scFv immunotoxin. Our results demonstratethat position H44-L105 is the only one which gives high productionyields of active dsFv. All other positions gave either low yieldsand activity or completely failed to produce active dsFv. Withone exception, the formation and activities of the dsFvs correspondedto the C-C distance between the VH and VL positions, with anoptimal distance of 5.7 Å producing the best dsFv. Distancesof 6.0–6.9 Å resulted in a' low yield of proteinthat was still capable of binding antigen, whereas distances>7.0 Å resulted in molecules in which dsFv formationwas not obtained.     

Escherichia coli Maltose-Binding Protein Induces M1 Polarity of RAW264.7 Macrophage Cells via a TLR2- and TLR4-Dependent Manner

Maltose-binding protein (MBP) is a critical player of the maltose/maltodextrin transport system in Escherichia coli. Our previous studies have revealed that MBP nonspecifically induces T helper type 1 (Th1) cell activation and activates peritoneal macrophages obtained from mouse. In the present study, we reported a direct stimulatory effect of MBP on RAW264.7 cells, a murine macrophage cell line. When stimulated with MBP, the production of nitric oxide (NO), IL-1β, IL-6 and IL-12p70, and the expressions of CD80, MHC class II and inducible nitric oxide synthase (iNOS) were all increased in RAW264.7 cells, indicating the activation and polarization of RAW264.7 cells into M1 macrophages induced by MBP. Further study showed that MBP stimulation upregulated the expression of TLR2 and TLR4 on RAW264.7 cells, which was accompanied by subsequent phosphorylation of IκB-α and p38 MAPK. Pretreatment with anti-TLR2 or anti-TLR4 antibodies largely inhibited the phosphorylation of IκB-α and p38 MAPK, and greatly reduced MBP-induced NO and IL-12p70 production, suggesting that the MBP-induced macrophage activation and polarization were mediated by TLR2 and TLR4 signaling pathways. The observed results were independent of lipopolysaccharide contamination. Our study provides a new insight into a mechanism by which MBP enhances immune responses and warrants the potential application of MBP as an immune adjuvant in immune therapies.